Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.

导出 OA

翻译打印收藏纠错

作者： Valentino,Rački ^[1] ; Mario,Hero ^[2] ; Eliša,Papić ^[1] ; Gloria,Rožmarić ^[2] ; Nada Starčević,Čizmarević ^[1] ; Darko,Chudy ^[2] ; Borut,Peterlin ^[1] ; Vladimira,Vuletić ^[3]

作者单位： Department of Neurology, Clinical Hospital Center Rijeka, Rijeka, Croatia. ^[1] Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia. ^[2] Department of Medical Genomics and Biology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia. ^[3] Department of Neurosurgery, Clinical Hospital Dubrava, Zagreb, Croatia. ^[4] Clinical Institute of Genomic Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia. ^[5]

关键词 Parkinson’s disease deep brain stimulation dystonia genetic testing whole-exome sequencing

DOI 10.3389/fnins.2023.1282267

PMID 38027472

发布时间 2023-12-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in neuroscience

2023年17卷

1282267页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson's disease and monogenic dystonia: a multidisciplinary team perspective.

Frontiers in neuroscience

相似文献

Frontiers in neuroscience

相关期刊

检索历史清除